Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Pathway name | Related literatures |
---|
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Ibrahim HN et al. | Parenteral iron use: possible contribution to exceeding target hemoglobin in hemodialysis patients. | 2009 | Clin J Am Soc Nephrol | pmid:19211669 |
Haddad A et al. | Use of iron sucrose in dialysis patients sensitive to iron dextran. | 2009 | Saudi J Kidney Dis Transpl | pmid:19237805 |
Pollak VE et al. | The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data. | 2009 | BMC Nephrol | pmid:19245700 |
Torres-Corzo JG et al. | Comparison of cerebrospinal fluid obtained by ventricular endoscopy and by lumbar puncture in patients with hydrocephalus secondary to neurocysticercosis. | 2009 | Surg Neurol | pmid:19249584 |
Clark SF | Iron deficiency anemia: diagnosis and management. | 2009 | Curr. Opin. Gastroenterol. | pmid:19262200 |
Muñoz M et al. | [Usefulness of the administration of intravenous iron sucrose for the correction of preoperative anemia in major surgery patients]. | 2009 | Med Clin (Barc) | pmid:19264195 |
Vanin S et al. | Seasonal variation of trehalose and glycerol concentrations in winter snow-active insects. | 2008 Nov-Dec | Cryo Letters | pmid:19280052 |
Breborowicz A et al. | Intravenous iron sucrose changes the intraperitoneal homeostasis. | 2009 | Blood Purif. | pmid:19325240 |
Lindgren S et al. | Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study. | 2009 | Scand. J. Gastroenterol. | pmid:19330567 |
Kim YH et al. | Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study. | 2009 | Acta Haematol. | pmid:19332985 |
Zanor MI et al. | Metabolic characterization of loci affecting sensory attributes in tomato allows an assessment of the influence of the levels of primary metabolites and volatile organic contents. | 2009 | J. Exp. Bot. | pmid:19346240 |
Gorder V et al. | Treatment of restless legs syndrome with iron infusion therapy. | 2009 | JAAPA | pmid:19354112 |
Nakamura Y et al. | Decreased valproate level caused by VPA-glucuronidase inhibition by carbapenem antibiotics. | 2008 | Drug Metab Lett | pmid:19356106 |
De Saint-Hubert M et al. | Molecular imaging of cell death. | 2009 | Methods | pmid:19362149 |
pmid:19379368 | ||||
Bencaiova G et al. | Iron prophylaxis in pregnancy: intravenous route versus oral route. | 2009 | Eur. J. Obstet. Gynecol. Reprod. Biol. | pmid:19406557 |
pmid:19432851 | ||||
Luo Z et al. | Resistin induces insulin resistance by both AMPK-dependent and AMPK-independent mechanisms in HepG2 cells. | 2009 | Endocrine | pmid:19440859 |
pmid:19481054 | ||||
Grote L et al. | A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome. | 2009 | Mov. Disord. | pmid:19489063 |
Kulnigg S et al. | Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment. | 2009 | Am. J. Gastroenterol. | pmid:19491860 |
Asma S et al. | Safety, therapeutic effectiveness, and cost of parenteral iron therapy. | 2009 | Int. J. Hematol. | pmid:19495930 |
GarcÃa-Erce JA et al. | Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study. | 2009 | Vox Sang. | pmid:19497085 |
Nguyen TV | Comparison of serum ferritin and transferrin saturation values associated with two i.v. iron formulations in hemodialysis patients. | 2009 | Am J Health Syst Pharm | pmid:19498125 |
Fontés G et al. | Involvement of Per-Arnt-Sim Kinase and extracellular-regulated kinases-1/2 in palmitate inhibition of insulin gene expression in pancreatic beta-cells. | 2009 | Diabetes | pmid:19502418 |
Krafft A et al. | Selective use of recombinant human erythropoietin in pregnant patients with severe anemia or nonresponsive to iron sucrose alone. | 2009 | Fetal. Diagn. Ther. | pmid:19506383 |
Toblli JE et al. | Differences between original intravenous iron sucrose and iron sucrose similar preparations. | 2009 | Arzneimittelforschung | pmid:19517894 |
Shimizu Y et al. | Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia. | 2009 | Bone | pmid:19555782 |
Li H and Wang SX | [Intravenous iron sucrose in maintenance dialysis patients with renal anemia: a clinical study]. | 2009 | Zhonghua Yi Xue Za Zhi | pmid:19567093 |
Yi CX et al. | A major role for perifornical orexin neurons in the control of glucose metabolism in rats. | 2009 | Diabetes | pmid:19592616 |
Barraclough KA et al. | Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial). | 2009 | BMC Nephrol | pmid:19635169 |
Dueber JE et al. | Synthetic protein scaffolds provide modular control over metabolic flux. | 2009 | Nat. Biotechnol. | pmid:19648908 |
Dong T and Schellhorn HE | Global effect of RpoS on gene expression in pathogenic Escherichia coli O157:H7 strain EDL933. | 2009 | BMC Genomics | pmid:19650909 |
DeLisa MP and Conrado RJ | Synthetic metabolic pipelines. | 2009 | Nat. Biotechnol. | pmid:19668178 |
pmid:19717754 | ||||
Edwards TJ et al. | Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery. | 2009 | Br J Surg | pmid:19731228 |
Gehret TC et al. | Convenient large-scale synthesis of D-glucaro-1,4:6,3-dilactone. | 2009 | J. Org. Chem. | pmid:19777999 |
Muñoz M et al. | Intravenous iron in inflammatory bowel disease. | 2009 | World J. Gastroenterol. | pmid:19787830 |
Smith TG et al. | Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials. | 2009 | JAMA | pmid:19809026 |
ComÃn-Colet J et al. | A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical outcomes. | 2009 | J. Card. Fail. | pmid:19879457 |
Ball LM et al. | Formation of mutagenic urinary metabolites from 1-nitropyrene in germ-free and conventional rats: role of the gut flora. | 1991 | Carcinogenesis | pmid:1988167 |
McMahon LP et al. | Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial. | 2010 | Nephrol. Dial. Transplant. | pmid:19906658 |
Orlandi C et al. | Early scintigraphic detection of experimental myocardial infarction in dogs with technetium-99m-glucaric acid. | 1991 | J. Nucl. Med. | pmid:1992031 |
Morimoto S et al. | Significance of urinary glucaric acid measurement and its application to paclitaxel therapy. | 2009 | Gan To Kagaku Ryoho | pmid:19920388 |
Gambini JP et al. | Evaluation of patients with head and neck cancer by means of 99mTc-glucarate. | 2009 | J Nucl Med Technol | pmid:19949020 |
Stancu S et al. | Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease? | 2010 | Clin J Am Soc Nephrol | pmid:20019121 |
Sienkiewicz-Porzucek A et al. | Mild reductions in mitochondrial NAD-dependent isocitrate dehydrogenase activity result in altered nitrate assimilation and pigmentation but do not impact growth. | 2010 | Mol Plant | pmid:20035036 |
Fior S and Gerola PD | Impact of ubiquitous inhibitors on the GUS gene reporter system: evidence from the model plants Arabidopsis, tobacco and rice and correction methods for quantitative assays of transgenic and endogenous GUS. | 2009 | Plant Methods | pmid:20042078 |
Ginsberg G and Rice DC | Does rapid metabolism ensure negligible risk from bisphenol A? | 2009 | Environ. Health Perspect. | pmid:20049111 |
Dangsuwan P and Manchana T | Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy. | 2010 | Gynecol. Oncol. | pmid:20051288 |